Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease

1. Global Initiative for Chronic Obstructive Lung Disease, GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD, GOLD, Barcelona, January 2017; http://goldcopd.org; last access date September 29, 2017.Search in Google Scholar

2. World Health Organization, Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015, WHO, Geneva 2016; http://www.who.int/entity/healthinfo/global_burden_disease/GHE2015_Deaths_Global_2000_2015.xls?ua=1; last access date November 6, 2017.Search in Google Scholar

3. R. D. Restrepo, M. T. Alvarez, L. D. Wittnebel, H. Sorenson, R. Wettstein, D. L. Vines, J. Sikkema-Ortiz, D. D. Gardner and R. L. Wilkins, Medication adherence issues in patients treated for COPD, Int. J. Chron. Obstruct. Pulmon. Dis. 3 (2008) 371−384; https://doi.org/10.2147/COPD.S3036.10.2147/COPD.S3036Search in Google Scholar

4. C. R. Wilson Van Voorhis and B. L. Morgan, Understanding power and rules of thumb for determining sample sizes, Tutor. Quant. Meth. Psychol. 3 (2007) 43−50; https://doi.org/10.20982/tqmp.03.2.p043.10.20982/tqmp.03.2.p043Search in Google Scholar

5. The American Thoracic Society, St. George’s Respiratory Questionnaire (SGRQ), New York, June 2016; http://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/sgrq.php; last access date September 29, 2017.Search in Google Scholar

6. D. E. Morisky, A. Ang, M. Krousel-Wood and H. J. Ward, Predictive validity of a medication adherence measure in an outpatient setting, J. Clin. Hypertens. (Greenwich) 10 (2008) 348−354; https://doi.org/10.1111/j.1751-7176.2008.07572.x.10.1111/j.1751-7176.2008.07572.xSearch in Google Scholar

7. M. Krousel-Wood, T. Islam, L. S. Webber, R. N. Re, D. E. Morisky and P. Muntner, New medication adherence scale versus pharmacy fill rates in seniors with hypertension, Am. J. Manag. Care 15 (2009) 59−66.Search in Google Scholar

8. D. E. Morisky and M. R. DiMatteo, Improving the measurement of self-reported medication nonadherence: response to authors, J. Clin. Epidemiol. 64 (2011) 255−257; https://doi.org/10.1016/j.jclinepi.2010.09.002.10.1016/j.jclinepi.2010.09.002Search in Google Scholar

9. F. Arpinelli, M. Carone, G. Riccardo and G. Bertolotti, Health-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literature, Multidiscip. Respir. Med. 11 (2016) Article ID 5 (7 pages); https://doi.org/10.1186/s40248-016-0040-9.10.1186/s40248-016-0040-9Search in Google Scholar

10. A. Ekici, E. Bulcun, T. Karakoc, E. Senturk and M. Ekici, Factors associated with quality of life in subjects with stable COPD, Respir. Care 60 (2015) 1585−1591; https://doi.org/10.4187/respcare.03904.10.4187/respcare.03904Search in Google Scholar

11. M. Ferrer, C. Villasante, J. Alonso, V. Sobradillo, R. Gabriel, G. Vilagut, J. F. Masa, J. L. Viejo, C. A. Jimenez-Ruiz and M. Miravitlles, Interpretation of quality of life scores from the St George’s respiratory questionnaire, Eur. Respir. J. 19 (2002) 405−413; https://doi.org/10.1183/09031936.02.0021320210.1183/09031936.02.00213202Search in Google Scholar

12. M. Miravitlles, M. Ferrer, A. Pont, R. Zalacain, J. L. Alvarez-Sala, F. Masa, H. Verea, C. Murio, F. Ros and R. Vidal, Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study, Thorax 59 (2004) 387−395; https://doi.org/10.1136/thx.2003.008730.10.1136/thx.2003.008730Search in Google Scholar

13. M. Miravitlles, J. B. Soriano, F. Garcia-Rio, L. Munoz, E. Duran-Tauleria, G. Sanchez, V. Sobradillo and J. Ancochea, Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities, Thorax 64 (2009) 863−868; https://doi.org/10.1136/thx.2009.115725.10.1136/thx.2009.115725Search in Google Scholar

14. J. G. van Manen, P. J. Bindels, F. W. Dekker, B. J. Bottema, J. S. van der Zee, C. J. Ijzermans and E. Schade, The influence of COPD on health-related quality of life independent of the influence of comorbidity, J. Clin. Epidemiol. 56 (2003) 1177−1184; https://doi.org/10.1016/S0895-4356(03)00208-7.10.1016/S0895-4356(03)00208-7Search in Google Scholar

15. M. R. Boland, J. F. van Boven, A. L. Kruis, N. H. Chavannes, T. van der Molen, L. M. Goossens and M. P. Rutten-van Molken, Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence, Respir. Med. 110 (2016) 34−45; https://doi.org/10.1016/j.rmed.2015.11.008.10.1016/j.rmed.2015.11.00826639189Search in Google Scholar